ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
accruals factor · long-only model fund

Foundry Earnings Quality (Accruals) Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FACRHYPOTHETICAL MODEL
Since ’99
−31%
Expense Ratio
0.35%
placeholder
Holdings
223
cap-weighted
Inception
Sep 2021
placeholder
Full Sharpe
-0.00
Ann. Return (LS)
-0.0%
Ann. Volatility
16.0%
Max Drawdown
-76.6%
Test Sharpe ’19–26
0.60
Test FF5 α (ann.)
11.3%
vs Fama-French 5
Test FF5 α t-stat
1.66
not significant
Monthly turnover
24%
of the long leg, per rebalance
Cumulative return (LS)
-31%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.52
what this fund holds
Long leg ann. return
10.9%
buyable, long-only
Long-short Sharpe
-0.00
requires shorting
Bottom bucket ann. return
10.9%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

223 of 223 · 100.0% of book
TickerCompanySectorMarket capWeight
1NFLX
NETFLIX INCCommunication Services$290.47B
14.55%
2GEV
GE VERNOVA INCUtilities$284.26B
14.24%
3BA
BOEING COIndustrials$168.72B
8.45%
4MO
ALTRIA GROUP INCConsumer Defensive$123.92B
6.21%
5SNOW
SNOWFLAKE INCTechnology$93.20B
4.67%
6TTWO
TAKE TWO INTERACTIVE SOFTWARE INCCommunication Services$43.94B
2.20%
7COIN
COINBASE GLOBAL INCFinancial Services$41.40B
2.07%
8CBRE
CBRE GROUP INCReal Estate$41.28B
2.07%
9AXON
AXON ENTERPRISE INCIndustrials$41.13B
2.06%
10CRWV
COREWEAVE INCTechnology$39.94B
2.00%
11RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
1.98%
12WDAY
WORKDAY INCTechnology$35.76B
1.79%
13EXPE
EXPEDIA GROUP INCIndustrials$32.26B
1.62%
14DXCM
DEXCOM INCHealthcare$29.58B
1.48%
15JBHT
HUNT J B TRANSPORT SERVICES INCIndustrials$27.48B
1.38%
16ECHO
ECHO GLOBAL LOGISTICS INCIndustrials$26.66B
1.34%
17CPRT
COPART INCIndustrials$25.56B
1.28%
18VRSN
VERISIGN INCTechnology$25.27B
1.27%
19MDB
MONGODB INCTechnology$25.12B
1.26%
20MRNA
MODERNA INCHealthcare$24.53B
1.23%
21CPAY
CORPAY INCTechnology$23.91B
1.20%
22UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
1.14%
23RIVN
RIVIAN AUTOMOTIVE INCConsumer Cyclical$22.00B
1.10%
24IFF
INTERNATIONAL FLAVORS & FRAGRANCES INCBasic Materials$19.96B
1.00%
25JLL
JONES LANG LASALLE INCReal Estate$15.34B
0.77%
26CRCL
CIRCLE INTERNET GROUP INCFinancial Services$15.03B
0.75%
27BTSG
BRIGHTSPRING HEALTH SERVICES INCHealthcare$13.71B
0.69%
28KNX
KNIGHT-SWIFT TRANSPORTATION HOLDINGS INCIndustrials$12.46B
0.62%
29BMRN
BIOMARIN PHARMACEUTICAL INCHealthcare$11.52B
0.58%
30HUBS
HUBSPOT INCTechnology$11.49B
0.58%
31HUT
HUT 8 CORPFinancial Services$10.30B
0.52%
32CYTK
CYTOKINETICS INCHealthcare$9.98B
0.50%
33HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.46%
34WULF
TERAWULF INCFinancial Services$9.00B
0.45%
35OSCR
OSCAR HEALTH INCHealthcare$8.77B
0.44%
36ZG
ZILLOW GROUP INCCommunication Services$7.71B
0.39%
37MIRM
MIRUM PHARMACEUTICALS INCHealthcare$7.25B
0.36%
38CIFR
CIPHER DIGITAL INCFinancial Services$7.18B
0.36%
39DBX
DROPBOX INCTechnology$7.14B
0.36%
40HNGE
HINGE HEALTH INCHealthcare$6.74B
0.34%
41CORZ
CORE SCIENTIFIC INCTechnology$6.66B
0.33%
42LUMN
LUMEN TECHNOLOGIES INCCommunication Services$6.47B
0.32%
43SRRK
SCHOLAR ROCK HOLDING CORPHealthcare$6.33B
0.32%
44MYRG
MYR GROUP INCIndustrials$6.10B
0.31%
45LYFT
LYFT INCTechnology$5.89B
0.30%
46CAR
AVIS BUDGET GROUP INCIndustrials$5.67B
0.28%
47ENPH
ENPHASE ENERGY INCTechnology$5.48B
0.27%
48PEGA
PEGASYSTEMS INCTechnology$5.39B
0.27%
49HRB
H&R BLOCK INCConsumer Cyclical$5.33B
0.27%
50TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.26%
51LAUR
LAUREATE EDUCATION INCConsumer Defensive$5.10B
0.26%
52DFTX
DEFINIUM THERAPEUTICS INCHealthcare$4.83B
0.24%
53LBRDA
LIBERTY BROADBAND CORPCommunication Services$4.43B
0.22%
54VKTX
VIKING THERAPEUTICS INCHealthcare$4.31B
0.22%
55ALHC
ALIGNMENT HEALTHCARE INCHealthcare$4.26B
0.21%
56ACLS
AXCELIS TECHNOLOGIES INCTechnology$4.19B
0.21%
57MARA
MARA HOLDINGS INCFinancial Services$4.08B
0.20%
58LION
LIONSGATE STUDIOS CORPCommunication Services$4.03B
0.20%
59DOCS
DOXIMITY INCHealthcare$3.94B
0.20%
60TDS
TELEPHONE & DATA SYSTEMS INCCommunication Services$3.90B
0.20%
61RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.19%
62PTEN
PATTERSON UTI ENERGY INCEnergy$3.80B
0.19%
63DNLI
DENALI THERAPEUTICS INCHealthcare$3.70B
0.19%
64MSGE
MADISON SQUARE GARDEN ENTERTAINMENT CORPConsumer Cyclical$3.56B
0.18%
65CRGY
CRESCENT ENERGY COEnergy$3.55B
0.18%
66RNG
RINGCENTRAL INCTechnology$3.46B
0.17%
67RCUS
ARCUS BIOSCIENCES INCHealthcare$3.44B
0.17%
68CLSK
CLEANSPARK INCFinancial Services$3.34B
0.17%
69SEDG
SOLAREDGE TECHNOLOGIES INCTechnology$3.25B
0.16%
70CWK
CUSHMAN & WAKEFIELD LTDReal Estate$3.20B
0.16%
71AD
ARRAY DIGITAL INFRASTRUCTURE INCCommunication Services$3.02B
0.15%
72FRSH
FRESHWORKS INCTechnology$3.01B
0.15%
73BRZE
BRAZE INCTechnology$2.98B
0.15%
74RARE
ULTRAGENYX PHARMACEUTICAL INCHealthcare$2.88B
0.14%
75LCID
LUCID GROUP INCConsumer Cyclical$2.87B
0.14%
76SUPN
SUPERNUS PHARMACEUTICALS INCHealthcare$2.79B
0.14%
77CLDX
CELLDEX THERAPEUTICS INCHealthcare$2.77B
0.14%
78NMRK
NEWMARK GROUP INCReal Estate$2.77B
0.14%
79VERA
VERA THERAPEUTICS INCHealthcare$2.76B
0.14%
80NVTS
NAVITAS SEMICONDUCTOR CORPTechnology$2.68B
0.13%
81KOD
KODIAK SCIENCES INCHealthcare$2.67B
0.13%
82TALO
TALOS ENERGY INCEnergy$2.49B
0.12%
83BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.12%
84AGIO
AGIOS PHARMACEUTICALS INCHealthcare$2.36B
0.12%
85BHVN
BIOHAVEN LTDHealthcare$2.32B
0.12%
86NOG
NORTHERN OIL & GAS INCEnergy$2.24B
0.11%
87IOVA
IOVANCE BIOTHERAPEUTICS INCHealthcare$2.23B
0.11%
88SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.11%
89AGL
AGILON HEALTH INCHealthcare$2.17B
0.11%
90PPTA
PERPETUA RESOURCES CORPBasic Materials$2.11B
0.11%
91VERX
VERTEX INCTechnology$2.07B
0.10%
92CDNA
CAREDX INCHealthcare$2.05B
0.10%
93SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.10%
94INOD
INNODATA INCTechnology$1.99B
0.10%
95AMLX
AMYLYX PHARMACEUTICALS INCHealthcare$1.97B
0.10%
96NGL
NGL ENERGY PARTNERS LPEnergy$1.89B
0.09%
97CPRI
CAPRI HOLDINGS LTDConsumer Cyclical$1.89B
0.09%
98SAM
BOSTON BEER CO INCConsumer Defensive$1.86B
0.09%
99MQ
MARQETA INCTechnology$1.85B
0.09%
100NVCR
NOVOCURE LTDHealthcare$1.84B
0.09%
101LIND
LINDBLAD EXPEDITIONS HOLDINGS INCIndustrials$1.81B
0.09%
102ASAN
ASANA INCTechnology$1.77B
0.09%
103ZYME
ZYMEWORKS INCHealthcare$1.77B
0.09%
104AESI
ATLAS ENERGY SOLUTIONS INCEnergy$1.76B
0.09%
105ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.08%
106CMPS
COMPASS PATHWAYS PLCHealthcare$1.67B
0.08%
107TE
T1 ENERGY INCIndustrials$1.63B
0.08%
108VIR
VIR BIOTECHNOLOGY INCHealthcare$1.59B
0.08%
109NTLA
INTELLIA THERAPEUTICS INCHealthcare$1.59B
0.08%
110BRUN
BOOST RUN INCTechnology$1.50B
0.08%
111AHCO
ADAPTHEALTH CORPHealthcare$1.49B
0.07%
112TRS
TRIMAS CORPConsumer Cyclical$1.46B
0.07%
113MLTX
MOONLAKE IMMUNOTHERAPEUTICSHealthcare$1.45B
0.07%
114YELP
YELP INCCommunication Services$1.44B
0.07%
115MRTN
MARTEN TRANSPORT LTDIndustrials$1.44B
0.07%
116AIP
ARTERIS INCTechnology$1.43B
0.07%
117CXM
SPRINKLR INCTechnology$1.37B
0.07%
118AMN
AMN HEALTHCARE SERVICES INCHealthcare$1.36B
0.07%
119REAL
THEREALREAL INCConsumer Cyclical$1.35B
0.07%
120BW
BABCOCK & WILCOX ENTERPRISES INCIndustrials$1.35B
0.07%
121DMLP
DORCHESTER MINERALS LPEnergy$1.31B
0.07%
122FCEL
FUELCELL ENERGY INCIndustrials$1.25B
0.06%
123CMP
COMPASS MINERALS INTERNATIONAL INCBasic Materials$1.24B
0.06%
124HTLD
HEARTLAND EXPRESS INCIndustrials$1.19B
0.06%
125CVLG
COVENANT LOGISTICS GROUP INCIndustrials$1.19B
0.06%
126MMI
MARCUS & MILLICHAP INCReal Estate$1.18B
0.06%
127MGTX
MEIRAGTX HOLDINGS PLCHealthcare$1.15B
0.06%
128EYPT
EYEPOINT INCHealthcare$1.12B
0.06%
129PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.05%
130FBRX
FORTE BIOSCIENCES INCHealthcare$1.00B
0.05%
131EVC
ENTRAVISION COMMUNICATIONS CORPCommunication Services$984M
0.05%
132KURA
KURA ONCOLOGY INCHealthcare$964M
0.05%
133ANNX
ANNEXON INCHealthcare$950M
0.05%
134GLIBA
GCI LIBERTY INCCommunication Services$881M
0.04%
135REPL
REPLIMUNE GROUP INCHealthcare$859M
0.04%
136CYRX
CRYOPORT INCIndustrials$832M
0.04%
137CODI
COMPASS DIVERSIFIED HOLDINGSIndustrials$777M
0.04%
138REPX
RILEY EXPLORATION PERMIAN INCEnergy$759M
0.04%
139IBTA
IBOTTA INCTechnology$734M
0.04%
140AURA
AURA BIOSCIENCES INCHealthcare$723M
0.04%
141SXC
SUNCOKE ENERGY INCBasic Materials$710M
0.04%
142SPRY
ARS PHARMACEUTICALS INCHealthcare$695M
0.03%
143PKE
PARK AEROSPACE CORPIndustrials$677M
0.03%
144SWBI
SMITH & WESSON BRANDS INCIndustrials$665M
0.03%
145VTS
VITESSE ENERGY INCEnergy$664M
0.03%
146ACHV
ACHIEVE LIFE SCIENCES INCHealthcare$644M
0.03%
147MEC
MAYVILLE ENGINEERING COMPANY INCIndustrials$634M
0.03%
148RGR
STURM RUGER & CO INCIndustrials$604M
0.03%
149PUBM
PUBMATIC INCTechnology$591M
0.03%
150NGNE
NEUROGENE INCHealthcare$590M
0.03%
151ETD
ETHAN ALLEN INTERIORS INCConsumer Cyclical$580M
0.03%
152WEAV
WEAVE COMMUNICATIONS INCHealthcare$575M
0.03%
153EGY
VAALCO ENERGY INCEnergy$553M
0.03%
154CTRN
CITI TRENDS INCConsumer Cyclical$535M
0.03%
155ARVN
ARVINAS INCHealthcare$517M
0.03%
156ADV
ADVANTAGE SOLUTIONS INCCommunication Services$508M
0.03%
157OIS
OIL STATES INTERNATIONAL INCEnergy$507M
0.03%
158TRC
TEJON RANCH COIndustrials$491M
0.02%
159SPIR
SPIRE GLOBAL INCIndustrials$488M
0.02%
160PAYS
PAYSIGN INCTechnology$478M
0.02%
161VMD
VIEMED HEALTHCARE INCHealthcare$466M
0.02%
162AMCX
AMC GLOBAL MEDIA INCCommunication Services$461M
0.02%
163STRZ
STARZ ENTERTAINMENT CORPCommunication Services$450M
0.02%
164SRTA
STRATA CRITICAL MEDICAL INCIndustrials$446M
0.02%
165BOC
BOSTON OMAHA CORPCommunication Services$430M
0.02%
166ASPN
ASPEN AEROGELS INCBasic Materials$425M
0.02%
167MCFT
MASTERCRAFT BOAT HOLDINGS INCConsumer Cyclical$407M
0.02%
168ENTA
ENANTA PHARMACEUTICALS INCHealthcare$400M
0.02%
169EBS
EMERGENT BIOSOLUTIONS INCHealthcare$394M
0.02%
170ABTC
AMERICAN BITCOIN CORPFinancial Services$386M
0.02%
171UPB
UPSTREAM BIO INCHealthcare$382M
0.02%
172ULH
UNIVERSAL LOGISTICS HOLDINGS INCIndustrials$377M
0.02%
173ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.02%
174MTRX
MATRIX SERVICE COIndustrials$342M
0.02%
175RTAC
RENATUS TACTICAL ACQUISITION CORP IIndustrials$329M
0.02%
176VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.02%
177PAMT
PAMT CORPIndustrials$311M
0.02%
178FHTX
FOGHORN THERAPEUTICS INCHealthcare$305M
0.02%
179ALCO
ALICO INCConsumer Defensive$304M
0.02%
180PNRG
PRIMEENERGY RESOURCES CORPEnergy$302M
0.02%
181TKNO
ALPHA TEKNOVA INCHealthcare$291M
0.01%
182UCFI
CN HEALTHY FOOD TECH GROUP CORPConsumer Defensive$288M
0.01%
183TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.01%
184ALMU
AELUMA INCTechnology$267M
0.01%
185SVCO
SILVACO GROUP INCTechnology$260M
0.01%
186VNME
VENDOME ACQUISITION CORP IIndustrials$254M
0.01%
187ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.01%
188GLSI
GREENWICH LIFESCIENCES INCHealthcare$240M
0.01%
189QUIK
QUICKLOGIC CORPTechnology$237M
0.01%
190RMAX
RE/MAX HOLDINGS INCReal Estate$236M
0.01%
191GTE
GRAN TIERRA ENERGY INCEnergy$233M
0.01%
192KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.01%
193PAL
PROFICIENT AUTO LOGISTICS INCIndustrials$197M
0.01%
194COOK
TRAEGER INCConsumer Cyclical$193M
0.01%
195EAF
GRAFTECH INTERNATIONAL LTDIndustrials$181M
0.01%
196KVHI
KVH INDUSTRIES INCTechnology$178M
0.01%
197INSE
INSPIRED ENTERTAINMENT INCConsumer Cyclical$174M
0.01%
198AOUT
AMERICAN OUTDOOR BRANDS INCIndustrials$174M
0.01%
199KORE
KORE GROUP HOLDINGS INCCommunication Services$163M
0.01%
200RCEL
AVITA MEDICAL INCHealthcare$157M
0.01%
201HOFT
HOOKER FURNISHINGS CORPConsumer Cyclical$152M
0.01%
202ACNT
ASCENT INDUSTRIES COBasic Materials$138M
0.01%
203DMRC
DIGIMARC CORPTechnology$133M
0.01%
204BOOM
DMC GLOBAL INCEnergy$128M
0.01%
205AARD
AARDVARK THERAPEUTICS INCHealthcare$128M
0.01%
206VATE
INNOVATE CORPIndustrials$123M
0.01%
207INSG
INSEEGO CORPTechnology$122M
0.01%
208TCX
TUCOWS INCTechnology$114M
0.01%
209SSTI
SOUNDTHINKING INCTechnology$111M
0.01%
210TRT
TRIO-TECH INTERNATIONALTechnology$103M
0.01%
211CHRN
CHRONOSCALE CORPIndustrials$94M
0.00%
212GEOS
GEOSPACE TECHNOLOGIES CORPEnergy$88M
0.00%
213RLYB
RALLYBIO CORPHealthcare$87M
0.00%
214AEYE
AUDIOEYE INCTechnology$82M
0.00%
215PIII
P3 HEALTH PARTNERS INCHealthcare$78M
0.00%
216ACET
ADICET BIO INCHealthcare$76M
0.00%
217SCLX
SCILEX HOLDING COHealthcare$72M
0.00%
218BGSF
BGSF INCIndustrials$65M
0.00%
219EDSA
EDESA BIOTECH INCHealthcare$59M
0.00%
220SKIL
SKILLSOFT CORPConsumer Defensive$58M
0.00%
221LNZA
LANZATECH GLOBAL INCIndustrials$56M
0.00%
222STEM
STEM INCTechnology$56M
0.00%
223EXOZ
EXOZYMES INCHealthcare$51M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $2.00T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

11 sectors
Communication Services
18.5%
Industrials
18.2%
Technology
16.0%
Healthcare
14.4%
Utilities
14.2%
Consumer Defensive
6.6%
Financial Services
4.5%
Real Estate
3.2%
Consumer Cyclical
2.0%
Basic Materials
1.2%
Energy
1.0%

Portfolio Style

Size × value map of the long-leg book

223 classified
Value
Blend
Growth
Large
Mid
Small
7%4
43%16
28%20
2%14
3%28
4%30
1%32
<1%19
<1%18

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 94% toward Large, 63% toward Growth. +12% unclassified (42 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt94% → Large
SmallLarge
Value ↔ growth tilt63% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 223 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
4
Failed
1
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 223 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.6 (95% CI 1.1-1.7)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
15.3%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.59x
within
parametric
1.33x
within
cornish fisher
1.31x
within

The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 20%; both still land on the same side of the 2x limit.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 1996
Entirely since publication
All 331 months of our record post-date the 1996 paper.
Sharpe -0.00-0.0% p.a.January 1999July 2026

There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
65%
17 of 26 3-year windows made money
Worst window
-1.01
Sharpe, January 2005 – December 2007
January 1999July 2026
Median Sharpe
0.14
Dispersion
0.63
Best window
1.24

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.18.5%10.2%
3 yearsp.a.24.6%0.2%
5 yearsp.a.13.8%6.0%
10 yearsp.a.17.8%7.4%
Since inceptionp.a.9.0%-1.3%
Calendar years
YearLong legLong-short
20267 mo10.3%11.5%
202524.1%-11.3%
202429.3%-8.7%
202362.0%43.4%
2022-36.3%6.4%
202136.4%13.1%
202045.7%18.8%
201921.0%6.8%
2018-1.1%19.3%
20177.9%-22.5%
201619.6%10.2%
201515.1%16.4%
201412.5%-0.7%
201342.6%-0.6%
201218.2%12.7%
2011-0.8%-5.0%
201012.7%-3.1%
200952.2%18.0%
2008-35.2%-8.9%
200712.6%-14.6%
200612.1%0.3%
20052.0%-14.4%
20043.6%-14.8%
200355.4%21.0%
2002-34.5%-9.1%
2001-18.9%-13.6%
2000-35.6%-23.9%
199913.6%-40.5%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FACR
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2021-09-08 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$2.00T

Methodology

The Foundry Earnings Quality (Accruals) Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a Earnings Quality (Accruals) signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.